Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease
- PMID: 12873849
- DOI: 10.1001/archneur.60.7.940
Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease
Abstract
Background: Dietary n-3 polyunsaturated fatty acids improve brain functioning in animal studies, but there is limited study of whether this type of fat protects against Alzheimer disease.
Objective: To examine whether fish consumption and intake of different types of n-3 fatty acids protect against Alzheimer disease.
Design: Prospective study conducted from 1993 through 2000, of a stratified random sample from a geographically defined community. Participants were followed up for an average of 3.9 years for the development of Alzheimer disease.
Patients: A total of 815 residents, aged 65 to 94 years, who were initially unaffected by Alzheimer disease and completed a dietary questionnaire on average 2.3 years before clinical evaluation of incident disease.
Main outcome measures: Incident Alzheimer disease diagnosed in a structured neurologic examination by means of standardized criteria.
Results: A total of 131 sample participants developed Alzheimer disease. Participants who consumed fish once per week or more had 60% less risk of Alzheimer disease compared with those who rarely or never ate fish (relative risk, 0.4; 95% confidence interval, 0.2-0.9) in a model adjusted for age and other risk factors. Total intake of n-3 polyunsaturated fatty acids was associated with reduced risk of Alzheimer disease, as was intake of docosahexaenoic acid (22:6n-3). Eicosapentaenoic acid (20:5n-3) was not associated with Alzheimer disease. The associations remained unchanged with additional adjustment for intakes of other dietary fats and of vitamin E and for cardiovascular conditions.
Conclusion: Dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimer disease.
Comment in
-
Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations?Arch Neurol. 2003 Jul;60(7):923-4. doi: 10.1001/archneur.60.7.923. Arch Neurol. 2003. PMID: 12873846 Review. No abstract available.
Similar articles
-
Intake of fish and n-3 fatty acids and future risk of metabolic syndrome.J Am Diet Assoc. 2010 Jul;110(7):1018-26. doi: 10.1016/j.jada.2010.04.013. J Am Diet Assoc. 2010. PMID: 20630158
-
Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men.N Engl J Med. 1995 Apr 13;332(15):977-82. doi: 10.1056/NEJM199504133321501. N Engl J Med. 1995. PMID: 7885425
-
Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids.Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1791-8. doi: 10.1158/1055-9965.EPI-06-0180. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035384
-
[Dietary fatty acids and colorectal and prostate cancers: epidemiological studies].Bull Cancer. 2005 Jul;92(7):670-84. Bull Cancer. 2005. PMID: 16123006 Review. French.
-
How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study.Curr Opin Lipidol. 2008 Feb;19(1):57-62. doi: 10.1097/MOL.0b013e3282f2e2a8. Curr Opin Lipidol. 2008. PMID: 18196988 Review.
Cited by
-
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease.Front Neurosci. 2024 Sep 11;18:1430465. doi: 10.3389/fnins.2024.1430465. eCollection 2024. Front Neurosci. 2024. PMID: 39323915 Free PMC article. Review.
-
Metal Toxicity and Dementia Including Frontotemporal Dementia: Current State of Knowledge.Antioxidants (Basel). 2024 Aug 1;13(8):938. doi: 10.3390/antiox13080938. Antioxidants (Basel). 2024. PMID: 39199184 Free PMC article. Review.
-
Fish consumption, cognitive impairment and dementia: an updated dose-response meta-analysis of observational studies.Aging Clin Exp Res. 2024 Aug 20;36(1):171. doi: 10.1007/s40520-024-02823-6. Aging Clin Exp Res. 2024. PMID: 39162889 Free PMC article.
-
Lifestyle Empowerment for Alzheimer's Prevention Prescribed by Physicians: Methods and Adaptations to COVID-19.medRxiv [Preprint]. 2024 Aug 1:2024.07.29.24311181. doi: 10.1101/2024.07.29.24311181. medRxiv. 2024. Update in: Contemp Clin Trials. 2024 Nov 2;147:107729. doi: 10.1016/j.cct.2024.107729 PMID: 39132486 Free PMC article. Updated. Preprint.
-
Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review.Yale J Biol Med. 2024 Jun 28;97(2):205-224. doi: 10.59249/JNKB9714. eCollection 2024 Jun. Yale J Biol Med. 2024. PMID: 38947104 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
